Individualized Grief Support With Swanson Model

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorSuleyman Demirel University

About this trial

This study aims to examine the effects of individualized grief support for women experiencing pregnancy loss. The research, which will be conducted at Süleyman Demirel University, is a mixed-method design and includes both phenomenological qualitative analysis and randomized controlled quantitative trials. The sample will include 48 women; those with severe depression will be excluded. Quantitative data will be analyzed using SPSS, and qualitative data will be analyzed using content analysis.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Aged 18 years and above,

Literate,

Able to understand and speak Turkish,

Desired and planned pregnancies

Disqualifiers

Women who experienced pregnancy loss after infertility treatment

Women who received psychological support during the process

Women who scored very high on the DAS scale

Women who withdrew from the study at any stage

Trial design

Design model

Parallel

Treatments tested in this trial

  • Assigned Interventions

    Other intervention

    Semi-structured interviews will be conducted with women who have experienced pregnancy loss, and their experiences and grieving processes will be examined phenomenologically. In the 3rd, 4th, and 5th interviews, based on the findings obtained from the qualitative data, grief counseling based on the Swanson care model will be provided to the women, and they will be provided with nursing care and grief support.

Treatment groups

48 Participants
are divided into 2 treatment groups
Group A: No intervention: Control GroupNo intervention 0 interventions
Group B: intervention groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Personal Information Form (Pre-Test)

This form will be administered to women during the initial interview after they are accepted into the service. It was developed by researchers to determine sociodemographic characteristics such as age, marital status, pregnancy history, and educational background. Women will also undergo pre-tests (PGS and DASS-21) during the initial interview.

Time frame
At baseline (prior to intervention)
2

Sociodemographic Characteristics Form

This form assesses participants' sociodemographic and obstetric characteristics, including age, marital status, educational level, and pregnancy history. The form is administered by the researcher during the initial interview after participants are accepted into the service.

Time frame
Baseline (pre-intervention)
3

Perinatal Grief Scale (PGS) Score

The Perinatal Grief Scale (PGS) is a self-report instrument used to assess grief intensity following pregnancy loss. The scale consists of 33 items rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 33 to 165, with higher scores indicating greater levels of perinatal grief.

Time frame
Baseline (pre-intervention)
4

Depression Anxiety Stress Scale-21 (DASS-21)

The Depression Anxiety Stress Scale-21 (DASS-21) is a self-report instrument used to assess symptoms of depression, anxiety, and stress. The scale consists of 21 items rated on a 4-point Likert scale ranging from 0 (did not apply to me at all) to 3 (applied to me very much or most of the time). The scale includes three subscales-Depression, Anxiety, and Stress-each comprising 7 items. Subscale scores are calculated by summing the relevant items and multiplying by two. Higher scores indicate greater symptom severity. Severity Classification: DASS-21 subscale scores are categorized as follows: Severity Level Depression Anxiety Stress Normal 0-4 0-3 0-7 Mild 5-6 4-5 8-9 Moderate 7-10 6-7 10-12 Severe 11-13 8-9 13-16 Extremely Severe ≥14 ≥10 ≥17

Time frame
Baseline (pre-intervention)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: